CDRH New - February 28, 2022

If your email program has trouble displaying this email, view as a webpage. February 28, 2022 The Center for Devices and Radiological Health (CDRH) posted these new items on FDA.gov on February 25, 2022. To view listings for other dates, see CDRH New - News and Updates. Revised Emergency Use Authorizations INDICAID COVID-19 Rapid Antigen Test (PHASE Scientific International, Ltd.) Revoked Emergency Use Authorizations BinaxNOW COVID-19 Ag Card 2 Home Test (Abbott Diagnostics Scarborough, Inc.) Reissued Emergency Use Authorizations Assurance SARS-CoV-2 Panel (Assurance Scientific Laboratories)  Assurance SARS-CoV-2 Panel DTC (Assurance Scientific Laboratories)  SalivaDirect for use with DTC Kits (Yale School of Public Health, Department of Epidemiology of Microbial Diseases) SalivaDirect DTC Saliva Collection Kit (Yale School of Public Health, Department of Epidemiology of Microbial Diseases)  1st Q FY 2022 MDUFA IV Performance Report

Follow us on Twitter at @FDADeviceInfo Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA